VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML
Product details
Registration number: SIN16514P
Classification: Prescription Only
Active ingredients: Faricimab
Strength: 6.00mg/0.05ml
Dosage form: INJECTION, SOLUTION
Route: INTRAVITREOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: S01LA09
HSA approval date: 16 June 2022
Manufacturer(s): F. Hoffmann-La Roche AG
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16514P
Classification: Prescription Only
What active ingredients and strength are recorded for VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Faricimab
Strength: 6.00mg/0.05ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVITREOUS
Who is the recorded registrant for VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): F. Hoffmann-La Roche AG
Manufacturing country/countries: SWITZERLAND
Where can I look up VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16514P or the exact product name VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML. The general register link does not preselect this product.
What are the source dates for this VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16514P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)